Published in Br J Surg on May 01, 2013
Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology (1986) 3.95
Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology (1993) 2.86
Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene (1997) 2.58
Duodenum-preserving resection of the head of the pancreas in patients with severe chronic pancreatitis. Surgery (1985) 2.41
Overexpression of HER2/neu oncogene in human pancreatic carcinoma. Hum Pathol (1993) 2.05
[The diagnostic value of the amino acid absorption test in detection of a disorder of exocrine pancreatic function]. Z Gastroenterol (1992) 2.02
Necrosectomy and postoperative local lavage in necrotizing pancreatitis. Br J Surg (1988) 1.81
Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation. Am J Transplant (2007) 1.76
Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer (1995) 1.67
Duodenum-preserving resection of the head of the pancreas in severe chronic pancreatitis. Early and late results. Ann Surg (1989) 1.66
Clinical significance of liver ischaemia after pancreatic resection. Br J Surg (2011) 1.59
Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res (1993) 1.53
A pancreatic cancer-specific expression profile. Oncogene (1996) 1.50
Interdigestive cycling in chronic pancreatitis: altered coordination among pancreatic secretion, motility, and hormones. Gastroenterology (1995) 1.47
Oxygen free radicals in acute pancreatitis of the rat. Gut (1990) 1.42
CMV infection in the donor and increased kidney graft loss: impact of full HLA-I mismatch and posttransplantation CD8(+) cell reduction. Am J Transplant (2013) 1.40
Importance of the duodenal passage and pouch volume after total gastrectomy and reconstruction with the Ulm pouch: prospective randomized clinical study. World J Surg (1996) 1.40
[Squamous cell carcinoma of the esophagus]. Chirurg (2011) 1.39
Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int J Cancer (2000) 1.39
Identification of pancreas necrosis in severe acute pancreatitis: imaging procedures versus clinical staging. Gut (1986) 1.32
Duodenum-preserving resection of the head of the pancreas in chronic pancreatitis with inflammatory mass in the head. World J Surg (1990) 1.27
Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease. Int J Pancreatol (1992) 1.26
Structure of Ribosomal Subunits of M. vannielii: Ribosomal Morphology as a Phylogenetic Marker. Science (1986) 1.25
Balance of expression of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in chronic pancreatitis. Z Gastroenterol (1994) 1.25
Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes. J Cell Biol (1995) 1.20
Morphogenesis and possible precursor lesions of invasive carcinoma of the papilla of Vater: epithelial dysplasia and adenoma. Hum Pathol (1985) 1.18
Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene. Cancer Res (1997) 1.17
PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas (1991) 1.14
Identification of genes with specific expression in pancreatic cancer by cDNA representational difference analysis. Genes Chromosomes Cancer (1997) 1.12
Synthesis and expression of transforming growth factor beta-1, beta-2, and beta-3 in the endocrine and exocrine pancreas. Diabetes (1993) 1.12
Oxygen radicals in experimental acute pancreatitis. Hepatogastroenterology (1994) 1.10
Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma. Gut (1998) 1.09
Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis. Am J Pathol (1994) 1.07
Hemodynamic data pattern in patients with acute pancreatitis. Gastroenterology (1986) 1.06
Interaction of pancreatic ductal carcinoma with nerves leads to nerve damage. Gastroenterology (1994) 1.04
Identification of a new tumour-associated antigen TM4SF5 and its expression in human cancer. Gene (1998) 1.02
Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane. FEBS Lett (1993) 1.01
A metastatic endocrine-neurogenic tumor of the ampulla of Vater with multiple endocrine immunoreaction--malignant paraganglioma? Digestion (1985) 1.00
Temporary placement of fully covered self-expandable metal stents in biliary complications after liver transplantation. Endoscopy (2012) 0.99
Mycophenolate mofetil in patients with systemic lupus erythematosus: a prospective pharmacokinetic study. Lupus (2009) 0.98
Differential expression of heat shock proteins in pancreatic carcinoma. Cancer Res (1994) 0.98
Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide. Gut (1995) 0.96
Neural alterations in surgical stage chronic pancreatitis are independent of the underlying aetiology. Gut (2002) 0.95
The canalicular multidrug resistance protein, cMRP/MRP2, a novel conjugate export pump expressed in the apical membrane of hepatocytes. Adv Enzyme Regul (1997) 0.95
[Value of biochemical and imaging procedures for the diagnosis and prognosis of acute pancreatitis--results of a prospective clinical study]. Z Gastroenterol (1986) 0.94
CA 19-9 and pancreatic adenocarcinoma. Cancer (1986) 0.94
Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis. Int J Cancer (1994) 0.94
Necrosectomy and postoperative local lavage in patients with necrotizing pancreatitis: results of a prospective clinical trial. World J Surg (1988) 0.94
Vasomotion in critically perfused muscle protects adjacent tissues from capillary perfusion failure. Am J Physiol Heart Circ Physiol (2000) 0.93
Efficacy and safety of early cyclosporine conversion to sirolimus with continued MMF-four-year results of the Postconcept study. Am J Transplant (2011) 0.93
Ratios of different serum pancreatic enzymes in the diagnosis and staging of chronic pancreatitis. Digestion (1993) 0.92
Comparative studies on the expression of tumor-associated glycoprotein (TAG-72), CA 19-9 and DU-PAN-2 in normal, benign and malignant pancreatic tissue. Int J Cancer (1988) 0.92
Exocrine pancreatic function in correlation to ductal and parenchymal morphology in chronic pancreatitis. Hepatogastroenterology (1986) 0.91
Free fatty acids in serum of patients with acute necrotizing or edematous pancreatitis. Int J Pancreatol (1993) 0.91
Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection. Dermatology (1997) 0.91
Vasopressor hormone response following mesenteric traction during major abdominal surgery. Acta Anaesthesiol Scand (1998) 0.91
Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy. Cancer Lett (2005) 0.90
The duodenum preserving resection of the head of the pancreas (DPRHP) in patients with chronic pancreatitis and an inflammatory mass in the head. An alternative surgical technique to the Whipple operation. Acta Chir Scand (1990) 0.90
ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancer. Digestion (1997) 0.90
Cloning of a new Kunitz-type protease inhibitor with a putative transmembrane domain overexpressed in pancreatic cancer. Biochim Biophys Acta (1998) 0.90
Pancreatic abscess and infected pancreatic necrosis. Different local septic complications in acute pancreatitis. Dig Dis Sci (1987) 0.89
A subgroup of patients with chronic pancreatitis overexpress the c-erb B-2 protooncogene. Ann Surg (1994) 0.89
Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study Group. Clin Investig (1994) 0.89
Inhibition of human exocrine pancreatic secretion by the long-acting somatostatin analogue octreotide (SMS 201-995). Aliment Pharmacol Ther (1992) 0.88
Effect of antioxidant treatment in rats with acute hemorrhagic pancreatitis. Dig Dis Sci (1994) 0.88
Met enkephalin-like immunoreactivity in Merkel cells. Cell Tissue Res (1979) 0.88
Treatment of duct carcinoma of the pancreas with the LH-RH analogue buserelin. Pancreas (1992) 0.87
Changes of protein gene product 9.5 (PGP 9.5) immunoreactive nerves in inflamed appendix. Dig Dis Sci (1995) 0.87
Pancreatic necrosis: an early finding in severe acute pancreatitis. Pancreas (1993) 0.87
Pancreatic morphology and function in relationship to pain in chronic pancreatitis. Int J Pancreatol (1987) 0.87
The role of oxygen radicals in experimental acute pancreatitis. Free Radic Biol Med (1992) 0.87
Reactivity of CO17-1A and B72.3 in benign and malignant pancreatic diseases. Hum Pathol (1989) 0.86
ATP-dependent export pumps and their inhibition by cyclosporins. Adv Enzyme Regul (1994) 0.86
Application of a gamma model of absorption to oral cyclosporin. Clin Pharmacokinet (2001) 0.86
Low-dose octreotide treatment is not effective in patients with advanced pancreatic cancer. Pancreas (1993) 0.86
The tachykinin neuroimmune connection in inflammatory pain. Ann N Y Acad Sci (1991) 0.86
Correlation of imaging and function in chronic pancreatitis. Radiol Clin North Am (1989) 0.86
Adhesion of Helicobacter pylori and Escherichia coli to human and bovine surface mucus cells in vitro. Eur J Clin Invest (1994) 0.86
[Lemierre's syndrome with splenic abscesses]. Dtsch Med Wochenschr (1992) 0.85
Beneficial effects of preventive oral administration of camostate on cerulein-induced pancreatitis in rats. Dig Dis Sci (1995) 0.84
Gastric and enteral pancreatic polypeptide (PP) immunoreactivity in the dog. Acta Histochem (1985) 0.84
Growth-associated protein-43 and protein gene-product 9.5 innervation in human pancreas: changes in chronic pancreatitis. Neuroscience (1994) 0.84
Serum phospholipase A2 in patients with multiple injuries. J Trauma (1990) 0.84
Possible association of c-Harvey-Ras-1 (HRAS-1) marker with autism. Psychiatry Res (1993) 0.84
Is increased pancreatic pressure related to pain in chronic pancreatitis? Int J Pancreatol (1994) 0.84
Sepsis indicators in acute pancreatitis. Pancreas (1987) 0.84
Exocrine pancreatic function in the early phase of human acute pancreatitis. Scand J Gastroenterol (1995) 0.83
Serum phospholipase A2 in patients with multiple organ failure. J Surg Res (1996) 0.83
[Clinical aspects and fine structure of papillary cancer. With special reference to morphological carcinogenesis]. Dtsch Med Wochenschr (1984) 0.83
Lipid peroxidation and glutathione metabolism in chronic pancreatitis. Pancreas (1995) 0.83
Adaptive changes of the exocrine pancreas and plasma cholecystokinin release following subtotal gastric resection in rats. Digestion (1987) 0.83
Fluorescein dilaurate serum test: a rapid tubeless pancreatic function test. Pancreas (1987) 0.82
Standards in monitoring acute experimental pancreatitis. Eur Surg Res (1992) 0.82
A ribosomal protein that is immunologically conserved in archaebacteria, eubacteria and eukaryotes. FEBS Lett (1984) 0.82
CA 494--a new tumor marker for the diagnosis of pancreatic cancer. Int J Cancer (1993) 0.82
Ultrastructure of human acute pancreatitis. Int J Pancreatol (1986) 0.82
Glucose homeostasis and endocrine pancreatic function in patients with chronic pancreatitis before and after surgical therapy. Pancreas (1994) 0.82
Indications for endoscopic or surgical therapy in chronic pancreatitis. Endoscopy (1991) 0.82
Early pulse pressure and low-grade proteinuria as independent long-term risk factors for new-onset diabetes mellitus after kidney transplantation. Am J Transplant (2008) 0.81